Can Laparoscopic Pancreaticoduodenectomy Be Safely Implemented?

Zureikat, Amer H.; Breaux, Jason A.; Steel, Jennifer L.; Hughes, Steven J.

doi:10.1007/s11605-011-1530-x

Cited by 129 publications

(100 citation statements)

References 23 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[17] 6.2/9 N/A 14.2%/0% N/A N/A 2.3/3.8 0%/0% 0 N/A Eom et al [18] 11.5/13.5 a 0 35.5%/24.2% N/A 9.7%/6.5% 3.95/6.15 a 9.7%/6.5% N/A N/A Kim et al [19] 10/16 a 0 24.7%/29% N/A 8.6%/14.3% 3/3 0 N/A N/A Matsumoto et al [20] 12.9/23.8 a 0 7.1%/21.1% N/A 0%/10.5% 3.0/3.4 0 N/A N/A Misawa et al [21] 10/16 a 0 N/A N/A 0%/22% 7.5/2 0%/0% N/A N/A Tang et al [22] 7/11 0 33.3%/0% N/A 22.2%/0% N/A 0%/0% 0%/0% N/A Teh et al [23] 6.2/10.6 a 0 16.7%/56.2% a 0 8.3%/6.2% 3.4/3.4 0%/0% N/A N/A Velanovich et al [24] 5/8 a N/A 20%/27% N/A 13%/13% N/A 20%/32% N/A N/A Fernández-Cruz et al [25] 6 pancreaticoduodenectomy. A summary of series that compare the pre-operative, intra-operative and post-operative factors and outcomes in MIPD and OPD at their institutions is shown in Tables 3 and 4 [35][36][37][38] .…”

Section: Oncologic Outcomesmentioning

confidence: 99%

“…The MIPD's rate of major morbidity in the series mentioned above ranges from 25%-48%, compared to 31% in OPD [50] . The rate of pancreatic fistulas is an important post-operative outcome and is reported in [36] N/A 20 N/A 31 21.9/22.9 NS N/A 80%/83.9% 656.6/554.6 376.6/1509.5 a 0 Zureikat et al [37] 14 N/A N/A 14 28.5/30 NS N/A 0/0 456/372 a 300/400 14% Cho et al [38] N [36] N/A N/A NS N/A 45%/39% N/A 0/12.9% N/A N/A Zureikat et al [37] 8/8. [38] 16.4/15.…”

Section: Post-operative Recoverymentioning

confidence: 99%

See 1 more Smart Citation

Laparoscopic pancreatectomy: Indications and outcomes

Liang

Hameed

Jayaraman

2014

WJG

View full text Add to dashboard Cite

The application of minimally invasive approaches to pancreatic resection for benign and malignant diseases has been growing in the last two decades. Studies have demonstrated that laparoscopic distal pancreatectomy (LDP) is feasible and safe, and many of them show that compared to open distal pancreatectomy, LDP has decreased blood loss and length of hospital stay, and equivalent post-operative complication rates and shortterm oncologic outcomes. LDP is becoming the procedure of choice for benign or small low-grade malignant lesions in the distal pancreas. Minimally invasive pancreaticoduodenectomy (MIPD) has not yet been widely adopted. There is no clear evidence in favor of MIPD over open pancreaticoduodenectomy in operative time, blood loss, length of stay or rate of complications. Robotic surgery has recently been applied to pancreatectomy, and many of the advantages of laparoscopy over open surgery have been observed in robotic surgery. Laparoscopic enucleation is considered safe for patients with small, benign or low-grade malignant lesions of the pancreas that is amenable to parenchyma-preserving procedure. As surgeons' experience with advanced laparoscopic and robotic skills has been growing around the world, new innovations and breakthrough in minimally invasive pancreatic procedures will evolve. Key words: Laparoscopy; Distal pancreatectomy; Pancreaticoduodenectomy; Robotic pancreatectomy; Enucleation Core tip: This review discusses recent advances in laparoscopic distal pancreatectomy (LDP), minimally invasive pancreaticoduodenectomy (MIPD), and enucleation. Recent studies show that LDP have improved perioperative recovery and equivalent oncologic outcomes. Studies on MIPD demonstrate that it is safe in terms of intra-operative outcomes, post-operative recovery and early oncologic outcomes; however, it requires advanced laparoscopic skills. Laparoscopic enucleation has become the operation of choice for small benign tumours that are away from the main pancreatic duct, especially insulinomas. We also summarize key results in pre-operative, perioperative and post-operative outcomes from contemporary series comparing open and laparoscopic pancreatic resections in the tables.

show abstract

Section: Oncologic Outcomesmentioning

confidence: 99%

Section: Post-operative Recoverymentioning

confidence: 99%

Laparoscopic pancreatectomy: Indications and outcomes

Liang

Hameed

Jayaraman

2014

WJG

View full text Add to dashboard Cite

show abstract

“…Technical progress in LPD was achieved by several pioneering laparoscopic surgeons, including hand-assisted LPD [9,10] as well as laparoscopically assisted [11,12] and robot-assisted PD [13]. However, some surgeons have recently reported favorable outcomes [14][15][16][17]. LPD has not been accepted as a generalized surgical method for the resection of pancreatic head lesions.…”

Section: Discussionmentioning

confidence: 99%

New Surgical Procedure for Pancreas Head

Sato¹,

Hara²,

Sawada³

et al. 2017

Challenges in Pancreatic Pathology

View full text Add to dashboard Cite

In this study, we demonstrate two new methods for pancreaticoduodenectomy (PD). One method is the mini-laparotomic PD by Shuriken-shaped umbilicoplasty with the real-time moving window's method. The other method is the new pancreaticojejunostomy (PJ) by punctured stent slide guiding method (PSSGM). This procedure could be performed by complete mini-laparotomy under direct vision, and the inal major wound is only 2 cm of round navel. PSSGM prevents the diference of caliber between pancreatic anastomosis and the inside out of jejunal mucosa in theory. Ten cases of mini-lap PD were successfully performed under new PJ anastomosis. The pancreatic leakage (PL) was only one case of ISGPF grade A, and its frequency was 9% (1/11). Our mini-lap PD by Shuriken-shaped umbilicoplasty might be a useful way for overcoming the obstacles about safety, complication risk, cosmetic demand, and medical cost compared to laparoscopic PD. Also, our new device of PJ reconstruction by PSSGM might be an easy and useful device for the prevention of PL.

show abstract

“…Laparoscopic pancreatoduodenectomy (LPD) was described first by (43)(44)(45). DOS was significantly shorter in several comparative studies (6 to 8 vs. 9 to 12.4 days, respectively) (40,43,44) whereas other studies (7,41) found no statistically significant difference. Conversion to open surgery was reported in 9.1% to 30.0% of cases, mostly due to venous invasion and intraoperative bleeding (7,44,46).…”

Section: Pancreatoduodenectomy (Pd)mentioning

confidence: 99%